Scientific article
Review
English

Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis

Published inAIDS, vol. 27, no. 7, p. 1135-1143
Publication date2013
Abstract

The risk of adverse drug events associated with nevirapine (NVP) is suggested to be greater in pregnant women. We conducted a systematic review and meta-analysis of severe adverse events in HIV-positive women who initiated NVP while pregnant.

Keywords
  • Adult
  • Anti-HIV Agents/administration & dosage/adverse effects
  • CD4 Lymphocyte Count
  • Female
  • HIV Seropositivity/drug therapy/immunology/transmission
  • Humans
  • Nevirapine/administration & dosage/adverse effects
  • Pregnancy
  • Pregnancy Complications, Infectious/drug therapy/immunology/virology
  • Risk Assessment
Research groups
Citation (ISO format)
FORD, Nathan et al. Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis. In: AIDS, 2013, vol. 27, n° 7, p. 1135–1143. doi: 10.1097/QAD.0b013e32835e0752
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0269-9370
608views
0downloads

Technical informations

Creation03/12/2013 15:50:00
First validation03/12/2013 15:50:00
Update14/03/2023 20:56:03
Status update14/03/2023 20:56:03
Last indexation30/10/2024 16:08:47
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack